ARCHIVES

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

September 28, 2007

Chemotherapy After Surgery Extends Survival By 32%

January 27, 2006

FDA Concerned About Data-Dredging In Drug-Diagnostic Applications

January 30, 2009

Clinical Trials Approved By NCI In November

December 28, 2001

Clolar Approved for Pediatric Refractory/Relapsed ALL

January 28, 2005

NAB Report To President Makes Pitch for Money, Cites Research Progress

August 9, 1974